Dr. Lo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-322-5000
Summary
- Dr. Justin Lo is an oncology specialist based in Nashville, TN, serving as an Instructor at Vanderbilt University Medical Center since 2023. He completed his MD-PhD at Harvard Medical School and MIT in 2017, followed by a residency in Internal Medicine and a fellowship in hematology and medical oncology at Vanderbilt University Medical Center. Dr. Lo's research is focused on developing new drug delivery technologies and combination strategies for treatment of GI cancers.
Education & Training
- Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2023
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2017 - 2019
- Harvard Medical SchoolClass of 2017
- Massachusetts Institute of TechnologyPhD, 2010 - 2015
Certifications & Licensure
- TN State Medical License 2022 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsStructural optimization of siRNA conjugates for albumin binding achieves effective MCL1-directed cancer therapy.Ella N Hoogenboezem, Shrusti S Patel, Justin H Lo, Ashley B Cavnar, Lauren M Babb
Nature Communications. 2024-02-21 - 20 citationsImmunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies.Justin H Lo, Rajiv Agarwal, Laura W Goff, Thatcher R Heumann
Cancers. 2023-06-23 - 7 citationsCore polymer optimization of ternary siRNA nanoparticles enhances in vivo safety, pharmacokinetics, and tumor gene silencing.Shrusti S Patel, Ella N Hoogenboezem, Fang Yu, Carlisle R DeJulius, R Brock Fletcher
Biomaterials. 2023-06-01
Press Mentions
- AACR and FDA Introduce New Fellowship ProgramDecember 10th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: